Deciphering the Interplay between the Epithelial Barrier, Immune Cells, and Metabolic Mediators in Allergic Disease

Lea Ling-Yu Kan,Peiting Li,Sharon Sze-Man Hon,Andrea Yi-Tung Lai,Aixuan Li,Katie Ching-Yau Wong,Danqi Huang,Chun-Kwok Wong

DOI: https://doi.org/10.3390/ijms25136913

IF: 5.6

2024-06-25

International Journal of Molecular Sciences

Abstract:Chronic exposure to harmful pollutants, chemicals, and pathogens from the environment can lead to pathological changes in the epithelial barrier, which increase the risk of developing an allergy. During allergic inflammation, epithelial cells send proinflammatory signals to group 2 innate lymphoid cell (ILC2s) and eosinophils, which require energy and resources to mediate their activation, cytokine/chemokine secretion, and mobilization of other cells. This review aims to provide an overview of the metabolic regulation in allergic asthma, atopic dermatitis (AD), and allergic rhinitis (AR), highlighting its underlying mechanisms and phenotypes, and the potential metabolic regulatory roles of eosinophils and ILC2s. Eosinophils and ILC2s regulate allergic inflammation through lipid mediators, particularly cysteinyl leukotrienes (CysLTs) and prostaglandins (PGs). Arachidonic acid (AA)-derived metabolites and Sphinosine-1-phosphate (S1P) are significant metabolic markers that indicate immune dysfunction and epithelial barrier dysfunction in allergy. Notably, eosinophils are promoters of allergic symptoms and exhibit greater metabolic plasticity compared to ILC2s, directly involved in promoting allergic symptoms. Our findings suggest that metabolomic analysis provides insights into the complex interactions between immune cells, epithelial cells, and environmental factors. Potential therapeutic targets have been highlighted to further understand the metabolic regulation of eosinophils and ILC2s in allergy. Future research in metabolomics can facilitate the development of novel diagnostics and therapeutics for future application.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the interaction mechanisms among epithelial barriers, immune cells and metabolic mediators in allergic diseases. Specifically, the paper aims to provide an overview of metabolic regulation in allergic asthma, atopic dermatitis (AD) and allergic rhinitis (AR), emphasizing their underlying mechanisms, phenotypic characteristics, and the role of eosinophils and group 2 innate lymphoid cells (ILC2s) in the metabolic regulation in these diseases. By analyzing the roles of lipid mediators, especially cysteinyl leukotrienes (CysLTs) and prostaglandins (PGs), the paper further reveals how these metabolites affect the functions and interactions of immune cells, especially in fatty acid metabolism. In addition, the paper also discusses the potential roles of metabolites in the treatment applications of allergic diseases, providing new perspectives and possible treatment targets for future research.

### Main research questions:
1. **The role of metabolic regulation in allergic diseases**: Explore the specific mechanisms and phenotypic characteristics of metabolic regulation in allergic asthma, atopic dermatitis and allergic rhinitis.
2. **Metabolic regulation of eosinophils and ILC2s**: Analyze in detail the metabolic regulation mechanisms of eosinophils and ILC2s in allergic inflammation, especially how they affect the inflammatory response through lipid mediators such as CysLTs and PGs.
3. **The role of metabolites in allergic diseases**: Explore the roles of specific metabolites (such as arachidonic acid (AA) - derived metabolites and sphingosine - 1 - phosphate (S1P)) in allergic diseases, and their significance as markers of immune dysfunction and epithelial barrier dysfunction.
4. **Future research directions**: Propose future research directions in the field of metabolomics to promote the development of new diagnostic and treatment methods.

### Key points:
- **Epithelial barrier**: Chronic exposure to harmful pollutants, chemicals and pathogens can lead to pathological changes in the epithelial barrier, increasing the risk of allergies.
- **Immune cells**: Epithelial cells send pro - inflammatory signals to group 2 innate lymphoid cells (ILC2s) and eosinophils during allergic inflammation, and these cells require energy and resources to mediate activation, cytokine/chemokine secretion and the mobilization of other cells.
- **Metabolic mediators**: Lipid mediators (such as CysLTs and PGs) play a key role in allergic inflammation, and eosinophils and ILC2s regulate allergic inflammation through these mediators.
- **Metabolic reprogramming**: Immune cells undergo metabolic reprogramming during activation, changing cell metabolism and energy output, thereby affecting cell effector functions and interactions with other cells.

Through these studies, the paper hopes to provide new insights into the complex mechanisms of allergic diseases and provide a scientific basis for future treatment strategies.